NanoVibronix News - NAOV

Company Name	Stock Ticker Symbol	Market	Type
NanoVibronix Inc	NAOV	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	0.75	08:34:45

Open Price	Low Price	High Price	Close Price	Prev Close
				0.75

more quote information »

Recent News

Date	Time	Source	Heading
4/09/2024	08:30	BW	NanoVibronix Issues Letter to Stockholders
3/28/2024	08:30	BW	NanoVibronix Signs Agreement for Research and Development of..
2/26/2024	17:32	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/23/2024	19:19	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/23/2024	19:18	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/23/2024	19:17	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/23/2024	19:15	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/14/2024	15:45	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
1/17/2024	16:31	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
1/17/2024	16:30	EDGAR2	Form 8-K - Current report
12/11/2023	16:30	EDGAR2	Form 8-K - Current report
12/06/2023	16:45	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/06/2023	09:00	BW	NanoVibronix Featured in Your Bladder Health Magazine
12/04/2023	20:45	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/04/2023	20:45	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/04/2023	20:45	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/04/2023	20:45	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/04/2023	16:45	EDGAR2	Form 8-K - Current report
12/04/2023	09:00	BW	NanoVibronix Enters into Letter of Intent with APOGEPHA..
11/28/2023	09:00	EDGAR2	Form 8-K - Current report
11/28/2023	09:00	BW	NanoVibronix Announces Agreement for Clinical Study of..
11/21/2023	08:30	EDGAR2	Form 8-K - Current report
11/21/2023	08:30	BW	NanoVibronix Regains Nasdaq Compliance
11/14/2023	08:30	BW	NanoVibronix Issues Letter to Shareholders
11/13/2023	16:44	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/07/2023	08:30	EDGAR2	Form 8-K - Current report
11/07/2023	08:30	BW	NanoVibronix UroShield Products Available on NHS Drug Tariff..
9/27/2023	08:00	EDGAR2	Form 8-K - Current report
9/27/2023	08:00	BW	NanoVibronix Gains Approval for Inclusion of UroShield..
9/22/2023	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
9/21/2023	10:27	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
9/21/2023	10:25	EDGAR2	Form RW - Registration Withdrawal Request
9/12/2023	16:15	EDGAR2	Form S-3 - Registration statement under Securities Act of..
9/06/2023	08:30	EDGAR2	Form 8-K - Current report
9/06/2023	08:30	BW	NanoVibronix Announces Presentation of Positive Independent..
9/01/2023	16:30	EDGAR2	Form 8-K - Current report
8/30/2023	14:29	BW	NanoVibronix Announces $5 Million Private Placement Priced..
8/30/2023	08:30	EDGAR2	Form 8-K - Current report
8/30/2023	08:30	BW	NanoVibronix Cites Positive Results from Independent Testing..
8/29/2023	16:05	EDGAR2	Form 8-K - Current report
8/29/2023	16:05	BW	NanoVibronix Responds to CMS’ Determination for PainShield
8/28/2023	08:30	EDGAR2	Form 8-K - Current report
8/28/2023	08:30	BW	NanoVibronix Applies for Inclusion of UroShield Products in..
8/23/2023	16:45	EDGAR2	Form 8-K - Current report
8/23/2023	08:45	BW	NanoVibronix Extends Distribution Agreement with Its Largest..
8/11/2023	17:20	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/07/2023	17:14	EDGAR2	Form S-1/A - General form for registration of securities..
8/01/2023	16:30	EDGAR2	Form S-3 - Registration statement under Securities Act of..
7/20/2023	16:45	EDGAR2	Form 8-K - Current report
7/17/2023	17:01	EDGAR2	Form S-1 - General form for registration of securities under..